eagle biosciences semaglutide elisa sensitivity Targeting GLP-1 receptor trafficking to improve agonist efficacy Assays Archives- Eagle Biosciences

Recently, Pfizer also successfully secured the ownership of GLP-1 biotechnology company Metsera after a surprise bidding conflict, adding Metseras injectable asset, MET-097i (which is in Phase 2b testing and has the potential for once-a-month dosing), to its portfolio

65 , e12525 (2018)

GLP-1 Medications and Breast Cancer: What the Latest Research Really Means Surviving Breast Cancer Jun 9 5 min read New research on Ozempic, Wegovy, and other GLP-1 medications is raising questions about breast cancer risk, treatment outcomes, and survivorship

References [1] Wilding, J

A 2024 analysis in Nicotine & Tobacco Research surveyed real-world reports from online health forums and found that roughly 30% of semaglutide users mentioned reduced smoking frequency, though causality could not be established